Comparison
Two growth-hormone-releasing hormone analogues that look similar on paper but sit on opposite sides of the approval line in Australia.
Both are GHRH analogues, but their regulatory status is very different: sermorelin has a legitimate prescription pathway, while CJC-1295 is not ARTG-approved and is usually sold through unregulated channels.
If a peptide in this class is being considered, the lawful, supervised route is the relevant one — not an online checkout.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.